₹178.45-2.10 (-1.16%)
09:51 AM, 5-Dec-2025₹178.47-2.38 (-1.32%)
09:39 AM, 5-Dec-2025BSE : 543635
NSE : PPLPHARMA
Sector : Health care
ISIN Code : INE0DK501011
Last Updated: 05-Dec-2025 | 09:51 AM IST
| Market Cap (₹ Cr) | 23,720 |
Traded Value (₹ Cr) | 0.40 |
Volume (Shares) | 22,619 |
Face Value (₹) | 10 |
52-Week High (₹) | 279.20 |
52-Week High Date | 05-Dec-2024 |
52-Week Low (₹) | 178.25 |
52-Week Low Date | 05-Dec-2025 |
All Time High (₹) | 307.85 |
All Time High Date | 06-Nov-2024 |
All Time Low (₹) | 61.65 |
All Time Low Date | 28-Mar-2023 |
| PARAMETER | VALUES |
|---|---|
| Market Cap (₹ Cr) | 23,693 |
| EPS - TTM (₹) [C] | -0.18 |
| P/E Ratio (X) [C] | -990.22 |
| Face Value (₹) | 10 |
| Latest Dividend (%) | 1.40 |
| Latest Dividend Date | 16-Jul-2025 |
| Dividend Yield (%) | 0.08 |
| Book Value Share (₹) [C] | 60.77 |
| P/B Ratio (₹) [C] | 2.93 |
| Scheme Name | Amount Invested (₹ Cr) | No Of Shares | Net Asset (%) |
|---|---|---|---|
| HDFC Flexi Cap Fund - (IDCW) | 1796.67 | 9,00,00,000 | 1.97 |
| HDFC Flexi Cap Fund - (G) | 1796.67 | 9,00,00,000 | 1.97 |
| HDFC Flexi Cap Fund - Direct (IDCW) | 1796.67 | 9,00,00,000 | 1.97 |
| HDFC Flexi Cap Fund - Direct (G) | 1796.67 | 9,00,00,000 | 1.97 |
| HDFC Focused Fund - Regular (G) | 541.00 | 2,71,00,000 | 2.15 |
| HDFC Focused Fund - Regular (IDCW) | 541.00 | 2,71,00,000 | 2.15 |
| HDFC Focused Fund - Direct (IDCW) | 541.00 | 2,71,00,000 | 2.15 |
| HDFC Focused Fund - Direct (G) | 541.00 | 2,71,00,000 | 2.15 |
| Bandhan Small Cap Fund (G) | 157.55 | 78,91,952 | 0.91 |
| Bandhan Small Cap Fund (IDCW) | 157.55 | 78,91,952 | 0.91 |
Load more
| Date | Broker | Action | Prices(₹) | Report |
|---|---|---|---|---|
| 03-Sep-2025 | JM Financial | Buy | 313 | |
| 20-Aug-2025 | JM Financial | Buy | 295 | |
| 25-Sep-2024 | Motilal Oswal | Buy | 260 |
| Today's Low/High (₹) | 178.24 181.62 |
| Week Low/High (₹) | 178.24 191.00 |
| Month Low/High (₹) | 178.24 203.00 |
| Year Low/High (₹) | 178.24 279.00 |
| All time Low/High (₹) | 61.65 308.00 |
| Period | BSE | NSE | SENSEX | NIFTY |
|---|---|---|---|---|
| 1 Week | -4.86% | -10.82% | -0.48% | -0.63% |
| 1 Month | -11.10% | -16.70% | 2.20% | 1.72% |
| 3 Month | -11.24% | -16.80% | 5.68% | 5.24% |
| 6 Month | -14.35% | -19.77% | 4.73% | 5.20% |
| 1 Year | -34.97% | -39.10% | 4.31% | 5.38% |
| 3 Year | 28.43% | 20.35% | 35.74% | 39.23% |
Chairperson : Nandini Piramal
Executive Director & CEO : PETER D DEYOUNG
Executive Director & CFO : Vivek Valsaraj
Non-Exec & Non-Independent Dir : Amit Jain
Independent Non Exe. Director : S Rama Dorai
Independent Non Exe. Director : Jairaj Manohar Purandare
Independent Non Exe. Director : Sridhar Gorthi
Independent Non Exe. Director : Peter Stevenson
Non-Exec & Non-Independent Dir : Nathalie Leitch
Independent Non Exe. Director : Vibha Paul Rishi
Company Sec. & Compli. Officer : Tanya Sanish
Registered Office: Ground Floor Piramal Ananta, Agastya Corp.Park LBS MargKurl,Mumbai,Maharashtra-400070 Ph: 91-22-3802-3000/4000
1. What's the Piramal Pharma Ltd share price today?
Piramal Pharma Ltd share price was Rs 178.45 at 09:51 AM IST on 5th Dec 2025. Piramal Pharma Ltd share price was down by 1.16% from the previous closing price of Rs 180.55. Piramal Pharma Ltd share price trend:
2. How can I quickly analyse the performance of the Piramal Pharma Ltd stock?
The performance of the Piramal Pharma Ltd stock can be quickly analysed on the following metrics:
3. What is the market cap of Piramal Pharma Ltd?
Piramal Pharma Ltd has a market capitalisation of Rs 23,720 crore.
4. What is Piramal Pharma Ltd's 52-week high/low share price?
The Piramal Pharma Ltd’s 52-week high share price is Rs 279.20 and 52-week low share price is Rs 178.25.
5. Is the Piramal Pharma Ltd profitable?
On a consolidated basis, Piramal Pharma Ltd reported a loss of Rs -99.22 crore on a total income of Rs 2,124.11 crore for the quarter ended 2025.
6. Which are Piramal Pharma Ltd’s peers in the Health care sector?
Piramal Pharma Ltd’s top 5 peers in the Health care sector are Gland Pharma, J B Chemicals &, Emcure Pharma, Piramal Pharma, Pfizer, Astrazeneca Phar, Wockhardt.
7. Who owns how much in Piramal Pharma Ltd?
Key changes to the Piramal Pharma Ltd shareholding are as follows: